Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christina M Brummett"'
Publikováno v:
Journal of Pharmacy Practice. 36:468-471
The growing use of oral factor Xa (FXa) inhibitors in patients with chronic kidney disease (CKD), particularly the recent increased use of apixaban in patients with end-stage renal disease (ESRD), has created a new dilemma in the already controversia
Publikováno v:
Open Forum Infectious Diseases
Background Advancements in laboratory diagnostics are constantly occurring and accuracy in interpreting results directly affects optimal patient care. The purpose of this process use evaluation was to assess the efficacy of our current presentation o